Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer [Phase 2]
Phase 2 clinical trial update examining etoposide capsules plus bevacizumab, iparomlimab, and tuvonralimab for platinum-resistant or platinu…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Genetic Testing Decision Aid [NA]
This clinical trial update reports a genetic testing decision aid study sponsored by Massachusetts General Hospital. It targets patients wit…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]
AB-1015 is an integrated circuit T cell therapy being studied in a Phase 1 trial for platinum-resistant epithelial ovarian cancer; the trial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Centralization and Oncologic Outcomes in Ovarian Cancer
Clinical trial update on centralization and oncologic outcomes in ovarian cancer; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) [Phase 1, Phase 2]
KL264-01, a Trop2-targeted antibody-drug conjugate, is being studied in a Phase 1/2 trial for advanced unresectable or metastatic solid tumo…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase II single-arm study evaluating Etigilimab (OMP-313M32) with nivolumab in platinum-resistant, recurrent epithelial ovarian cancer; the …
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and …
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Retrospective Evaluation of Minimally-Invasive Surgical Strategies in Ovarian Neoplasms (REMISSION Study)
The REMISSION study is a clinical trial evaluating minimally invasive surgical strategies for epithelial ovarian cancer to assess outcomes. …
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
This is a completed clinical trial update examining regional distribution of lymph node metastasis in epithelial ovarian cancer; results are…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tinzaparin and biomarker analyses after neoadjuvant treatment in epithelial ovarian cancer; the study…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) [Phase 3]
Phase 3 clinical trial SUNNY compares upfront surgery to neoadjuvant chemotherapy in advanced ovarian cancer. The study is currently active …
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma [Phase 1]
This is a Phase 1 study to evaluate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal junc…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
The PRODIGYN study is a prospective trial evaluating the added prognostic and diagnostic value of medical imaging in gynecologic cancers and…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating regulatory T-cell depletion with E7777 in combination with pembrolizumab for recurrent or metastatic e…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
Clinical trial update from Turku University Hospital evaluating how PET/CT staging correlates with chemotherapy response in epithelial ovari…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian Cancer [NA]
A clinical trial registered to evaluate sentinel lymph node mapping in the surgery of early epithelial ovarian cancer. The study is not yet …
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecolog…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]
This document reports a Phase 1 clinical trial of NI-1801 for mesothelin-expressing solid cancers, with recruiting status and multiple indic…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: The INFLUENCE of Cytoreduction on PRO in EOC
This clinical trial update covers a study on how cytoreduction influences patient-reported outcomes in epithelial ovarian cancer; the trial …
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: The Role of CircDENND4C in Epithelial Ovarian Cancer
A clinical trial by Assiut University is investigating CircDENND4C in epithelial ovarian cancer and is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery [NA]
Ongoing recruitment for a clinical study comparing rectosigmoid resection versus seromuscular tumor shaving in epithelial ovarian cancer wit…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Cukurova Score Validation Study
A clinical trial at Cukurova University is validating the Cukurova Score for epithelial ovarian cancer and is currently recruiting.